Oncovita
PrivateLast Round
VC Round
Jun 25, 2026
Total Funding Raised
$8.78M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Oncovita operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was an Angel round in November 2023.
Oncovita is a biotechnology company that develops virus-derived vaccine technology to treat various types of cancers and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oncovita Comparables
Compare Oncovita with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CanVirex AG | 85% | |
| Vyriad | 83% | |
| Imugene Ltd | 78% |
For institutional investors. Book with your work email.
Oncovita Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 25, 2026 | ||||
| Angel | Nov 29, 2023 | ||||
| Grant | Nov 29, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Oncovita Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
$23M raised in a VC Round.
- May 14, 2026
Monthly visitors increased 60% MoM.
For institutional investors. Book with your work email.
Oncovita Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Oncovita's valuation, stock price, and market status.
Is Oncovita a public or private company?
Oncovita is a private company.
What is the current stock price of Oncovita?
Oncovita is a private company, so its shares have no public market price. Caplight tracks Oncovita's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Oncovita worth (valuation)?
Valuation information for Oncovita is not publicly available.
Can I buy Oncovita stock?
Oncovita shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Oncovita's last funding round?
Oncovita's most recent funding round was VC Round on June 25, 2026.
Who are the main investors in Oncovita?
Key investors in Oncovita include Bpifrance.
Will Oncovita IPO soon?
No public IPO plans have been announced for Oncovita.
How can I track Oncovita secondary market activity?
Caplight tracks bids, offers, and trades in Oncovita's shares on secondary markets.